Proceedings of the National Academy of Sciences · 2015 · 469 citations · 40 references
PharmacyBiotechnologyMedicinal ChemistryNatural Product BiosynthesisPlant BiotechnologySynthetic BiologyAlkaloid BiosynthesisPlant Metabolic EngineeringPlant Natural Product BiosynthesisPlant Synthetic BiologyTerpenoid BiosynthesisAnticancer ActivityBioactive Plant CompoundsDeletionsIndole AlkaloidsMonoterpene BiosynthesisPlant AlkaloidsYeast Strain EngineeringYeast Strain Improvement
The monoterpene indole alkaloids are a large group of plant-derived specialized metabolites, many of which have valuable pharmaceutical or biological activity. There are ∼3,000 monoterpene indole alkaloids produced by thousands of plant species in numerous families. The diverse chemical structures found in this metabolite class originate from strictosidine, which is the last common biosynthetic intermediate for all monoterpene indole alkaloid enzymatic pathways. Reconstitution of biosynthetic pathways in a heterologous host is a promising strategy for rapid and inexpensive production of complex molecules that are found in plants. Here, we demonstrate how strictosidine can be produced de novo in a Saccharomyces cerevisiae host from 14 known monoterpene indole alkaloid pathway genes, along with an additional seven genes and three gene deletions that enhance secondary metabolism. This system provides an important resource for developing the production of more complex plant-derived alkaloids, engineering of nonnatural derivatives, identification of bottlenecks in monoterpene indole alkaloid biosynthesis, and discovery of new pathway genes in a convenient yeast host.
40
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
Dae‐Kyun Ro, Eric M. Paradise, Mario Ouellet et al. · Nature · 2006 · 2.8K citations
High-level semi-synthetic production of the potent antimalarial artemisinin
Christopher J. Paddon, Patrick J. Westfall, Douglas J. Pitera et al. · Nature · 2013 · 2.1K citations · Full text